Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Eli Lilly

Market Cap: US$994.9b

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Johnson & Johnson

Market Cap: US$620.8b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

AbbVie

Market Cap: US$435.1b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Merck

Market Cap: US$316.1b

Operates as a healthcare company worldwide.

AstraZeneca

Market Cap: UK£186.7b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Amgen

Market Cap: US$220.5b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Bristol-Myers Squibb

Market Cap: US$130.0b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Vertex Pharmaceuticals

Market Cap: US$122.9b

Operates as a biotechnology company in the United States, Europe, and internationally.

Chugai Pharmaceutical

Market Cap: JP¥11.1t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

WuXi AppTec

Market Cap: CN¥424.8b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

Galderma Group

Market Cap: CHF 41.6b

Operates as a dermatology company worldwide.

Jiangsu Hengrui PharmaceuticalsLtd

Market Cap: CN¥344.0b

A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

CSL

Market Cap: AU$63.4b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Haleon

Market Cap: UK£32.2b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Otsuka Holdings

Market Cap: JP¥6.4t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Teva Pharmaceutical Industries

Market Cap: US$40.5b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Natera

Market Cap: US$39.3b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Agilent Technologies

Market Cap: US$39.3b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Waters

Market Cap: US$39.3b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

IQVIA Holdings

Market Cap: US$38.9b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Sandoz Group

Market Cap: CHF 29.5b

Develops, manufactures, and markets generic and biosimilars worldwide.

Daiichi Sankyo Company

Market Cap: JP¥4.8t

Manufactures and sells pharmaceutical products in Japan and internationally.

Illumina

Market Cap: US$30.7b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Astellas Pharma

Market Cap: JP¥4.1t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

Hansoh Pharmaceutical Group

Market Cap: HK$192.1b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Innovent Biologics

Market Cap: HK$158.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

Sartorius Stedim Biotech

Market Cap: €16.9b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$121.4b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.

Ipsen

Market Cap: €13.1b

A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience in North America, Europe, and internationally.

Eurofins Scientific

Market Cap: €12.1b

Provides various analytical testing and laboratory services worldwide.

Orion Oyj

Market Cap: €11.5b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Revvity

Market Cap: US$12.8b

Provides health sciences solutions, technologies, and services.

Elanco Animal Health

Market Cap: US$12.8b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.7b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥81.9b

Manufactures and distributes pharmaceuticals and cosmetics in China and internationally.

ICON

Market Cap: US$12.1b

A clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.